Corning and SoftBank-backed dynamic glass producer View's previously announced reverse merger will be boosted by $200m from Singapore's sovereign wealth fund.

GV helped longtime portfolio company and database platform developer Cockroach Labs take its total funding to $355m at a $2bn valuation.

Monogenic disease therapy developer Lexeo Therapeutics has publicly launched with financing from backers including Lundbeckfonden Ventures.

Mitsui, Edison Energy, BMW, Daimler, General Motors and Exelon-backed electric bus manufacturer Proterra achieved a $1.6bn enterprise value in the deal.

TDK Ventures has exited the laser light source technology producer a year after an investment of undisclosed size.

The Workday, Salesforce and ServiceNow-backed workflow automation software provider boosted its valuation to $1.7bn and its overall funding to over $220m.

LifeMine’s chairman and co-founder Rick Klausner has co-led a round that included multiple corporates and pushed the overall equity to $120m.

IBM has bought 7Summits in a deal allowing the online consulting platform’s strategic partner, Salesforce, to exit.

Sanofi and Mass General Brigham contributed to a round that pushed the immunotherapy developer's total funding to nearly $60m.

The McKesson-backed software provider secured $44m in series D funding alongside the acquisition of healthcare software developer Mavens.